CN1745810A - Chinese medicinal pill for treating diabetes mellitus - Google Patents
Chinese medicinal pill for treating diabetes mellitus Download PDFInfo
- Publication number
- CN1745810A CN1745810A CN 200510086625 CN200510086625A CN1745810A CN 1745810 A CN1745810 A CN 1745810A CN 200510086625 CN200510086625 CN 200510086625 CN 200510086625 A CN200510086625 A CN 200510086625A CN 1745810 A CN1745810 A CN 1745810A
- Authority
- CN
- China
- Prior art keywords
- parts
- radix
- rhizoma
- portions
- diabetes
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
A Chinese medicine in the form of pill for treating diabetes and pancreatic disease is prepared from 13 Chinese-medicinal materials including Chuan-xiong rhizome, red sage root, ganoderma, aloe, etc.
Description
Technical field
The present invention relates to a kind of medicine pill for the treatment of diabetes, is various diabetes of a kind of main treatment and also can to treat other various pancreas diseases be the Chinese patent medicine of raw material with the Chinese herbal medicine.
Background technology
Diabetes are a kind of commonly encountered diseases, and pathogenic factor is a lot, think in the interior warp, and the spleen trauma, lung stomach kidney is scorching, is pathogenesis.After modern medicine thinks that human body is eaten food, food is through partes corporis humani's dissolving and digestion, with the residual drainage of slag, partly nutrition becomes blood glucose after dissolving, and blood glucose is subjected to the control of spleen institute, store for a long time, then slowly be transported to each organ after a little while, finish, but the diabetics above-mentioned functions lowers or stops the needs of human body and the function of adjusting, diabetics is polyphagia, polydipsia, polyuria, Light-headedness, lip and nail color green grass or young crops often, myasthenia of limbs.Diabetes also also have substantial connection with nervous system, and uneasiness angry and fidgetyly damages the lung stomach, cause the disorder of lung spleen and stomach function, the spleen disease is increasing, and is current, treatment liver diabetes Western medicine commonly used is advocated the long term injections insulin, and these Western medicine not only cost an arm and a leg, and toxic and side effects is also higher, and the utilization Chinese herbal treatment often adopts medicines such as diabetes pill or spleen-strengthening bolus, though said medicine has certain curative effect, but curative effect can not be satisfactory, and medicine cost height, the course of treatment is long, and amount of consumption of drugs is big.
Summary of the invention
The purpose of this invention is to provide a kind of medicine pill for the treatment of diabetes, can treat and effect a radical cure diabetes, and the medicine cost is low, short treating period, amount of consumption of drugs is few and be easy to take.Solution of the present invention is according to the rule of the traditional Chinese medical science to diabetes, i.e. the body resistance strengthening and constitution consolidating, and easypro lung is regulated the flow of vital energy, remove stagnated food, blood circulation promoting and dispersing pathogen accumulation, invigorating the spleen and regulating the stomach, the clearing away heat and relieving spasm method, the present invention forms according to above-mentioned rule, can the spasmolytic collateral dredging, blood circulation promoting and blood stasis dispelling, detoxifcation is gone dry, again can the body resistance strengthening and constitution consolidating, and easypro lung is regulated the flow of vital energy, hard masses softening and resolving, strengthening the spleen to promote digestion.Rhizoma Chuanxiong of the present invention, Rhizoma Cynanchi Stauntonii, Aloe, Radix Glehniae and Radix Rhodiolae removing the relative excess heat, promoting flow of QI and blood, the wind pain relieving of loosing, removing mass stagnates, pathogenic fire purging dampness, the relieving restlessness detoxifcation, lung moistening is regulated the flow of vital energy, by the capable water of expectorant; Fructus Psoraleae, the cool heart arresting convulsion of Ganoderma lucidum seu Japonicum, the strengthening the spleen stomach of feeling at ease, eliminating dampness and diuresis, clear heat and eliminate phlegm, spasmolytic detoxifcation; Pulvis Fumi Carbonisatus therapeutic method to keep the adverse QI flowing downwards Dingchuan eliminates indigestion and phlegm; Rhizoma Gymnadeniae, Rhizoma Polygonati, Radix Clematidis suppressing the hyperactive liver and easing the stomach, spleen reinforcing and in, the resolving depression of regulating the flow of vital energy, menstruction regulating and pain relieving; The Radix Salviae Miltiorrhizae eliminating blood stasis to promote regeneration of blood, promoting blood flow to regulate menstruation; Have eliminating evil just the wound, set upright and do not stay the evil effect of well curing the disease.
Make by the following weight proportion raw material:
30~40 parts of 36~48 parts of Radix Clematidis of 24~32 parts of Fructus Psoraleaes of Radix Rhodiolae
24~32 parts of 33~44 parts of Pulvis Fumi Carbonisatuss of 30~40 parts of Rhizoma Polygonatis of Rhizoma Chuanxiong
24~32 parts of 21~28 parts of Radix Salviae Miltiorrhizaes of 27~36 portions of Radix Glehniaes of Rhizoma Gymnadeniae
24~32 parts of 27~36 portions of Aloes of 21~28 portions of Ganoderma lucidum seu Japonicumes of Rhizoma Cynanchi Stauntonii
24~32 parts of Radix Oenotherae erythrosepalaes.
The weight proportion of each raw material of formula optimization of the present invention is:
32~38 parts of 38~46 parts of Radix Clematidis of 26~30 parts of Fructus Psoraleaes of Radix Rhodiolae
26~30 parts of 35~42 parts of Pulvis Fumi Carbonisatuss of 32~38 parts of Rhizoma Polygonatis of Rhizoma Chuanxiong
26~30 parts of 23~26 parts of Radix Salviae Miltiorrhizaes of 29~34 portions of Radix Glehniaes of Rhizoma Gymnadeniae
26~30 parts of 29~34 portions of Aloes of 23~26 portions of Ganoderma lucidum seu Japonicumes of Rhizoma Cynanchi Stauntonii
26~30 parts of Radix Oenotherae erythrosepalaes.
The weight proportion of best each raw material of prescription of the present invention is:
35 parts of 42 parts of Radix Clematidis of 28 parts of Fructus Psoraleaes of Radix Rhodiolae
28 parts of 37 parts of Pulvis Fumi Carbonisatuss of 35 parts of Rhizoma Polygonatis of Rhizoma Chuanxiong
28 parts of 24 parts of Radix Salviae Miltiorrhizaes of 31 portions of Radix Glehniaes of Rhizoma Gymnadeniae
28 parts of 31 portions of Aloes of 24 portions of Ganoderma lucidum seu Japonicumes of Rhizoma Cynanchi Stauntonii
28 parts of Radix Oenotherae erythrosepalaes.
Method for making of the present invention is with ladies and gentlemen's medicine drying and crushing to 80~120 order fine powders, with the fine powder mix homogeneously after the processing, make the dried noodle bulk with hydromel (Mel accounts for 20%, and water accounts for 80% and is mixed and made into), insert the patent medicine that is pressed into Semen phaseoli radiati grain size in the pellet processing machine again, the dry again moisture content of removing.Every 0.1 grammes per square metre, oral usually, one time 50, a twice-daily.Sooner or later respectively once, get final product produce effects common 6~15 times.
Clinical drug of the present invention uses the result to show that following advantage is arranged;
1, the Chinese herbal medicine each component selected for use of the present invention meets the pharmaceutical control law regulation, utilizes the comprehensive function treatment diabetes of the Chinese medicine of respectively distinguishing the flavor of, and does not have chemical sweeting agent, and harmless, safety of medicine is reliable.
2, the present invention need not decoct, no bitterness sense, rich in proteins in the medicine, glucose, phlegmatic temperament, organic acid, fatty oil, lecithin, multivitamin, carotene, various trace elements such as arginine and inorganic salt is beneficial to absorption of human body, health invigorating, and taking convenience.
3, the present invention can treat and effect a radical cure diabetes effectively, has improved patient's life quality and body constitution greatly, and higher healing rehabilitation efficacy is arranged.As follows through clinical test results for showing medicine of the present invention to the treatment of diabetes effect, treatment diabetics 67 examples, radical cure rehabilitation 30 examples, produce effects 12 examples, effective 15 examples, invalid 10 examples, effective percentage reaches more than 85%.The present invention is also also effective in cure to other pancreas disease, and the gastropathy effective percentage is reached more than 55%, and the pneumonopathy effective percentage is reached more than 35%.The present invention is called " pancreas ball ".
The specific embodiment
Take by weighing raw material by following proportioning:
Radix Rhodiolae 28g Fructus Psoraleae 42g Radix Clematidis 35g
Rhizoma Chuanxiong 35g Rhizoma Polygonati 37g Pulvis Fumi Carbonisatus 28g
Rhizoma Gymnadeniae 31g Radix Glehniae 24g Radix Salviae Miltiorrhizae 28g
Rhizoma Cynanchi Stauntonii 24g Ganoderma lucidum seu Japonicum 31g Aloe 28g
Radix Oenotherae erythrosepalae 28g.
Method for making of the present invention is with ladies and gentlemen's medicine drying and crushing to 80~120 order fine powders, with the fine powder mix homogeneously after the processing, make the dried noodle bulk with hydromel (Mel accounts for 20%, and water accounts for 80% and is mixed and made into), insert the patent medicine that is pressed into Semen phaseoli radiati grain size in the pellet processing machine again, the dry again moisture content of removing.Every 0.1 grammes per square metre, oral usually, one time 50, a twice-daily.Sooner or later respectively once, get final product produce effects common 6~15 times.
Claims (3)
1, a kind of medicine pill for the treatment of diabetes is characterized in that it is made by the following weight proportion raw material:
30~40 parts of 36~48 parts of Radix Clematidis of 24~32 parts of Fructus Psoraleaes of Radix Rhodiolae
24~32 parts of 33~44 parts of Pulvis Fumi Carbonisatuss of 30~40 parts of Rhizoma Polygonatis of Rhizoma Chuanxiong
24~32 parts of 21~28 parts of Radix Salviae Miltiorrhizaes of 27~36 portions of Radix Glehniaes of Rhizoma Gymnadeniae
24~32 parts of 27~36 portions of Aloes of 21~28 portions of Ganoderma lucidum seu Japonicumes of Rhizoma Cynanchi Stauntonii
24~32 parts of Radix Oenotherae erythrosepalaes.
2, a kind of medicine pill for the treatment of diabetes according to claim 1, wherein the weight proportion of each raw material is:
32~38 parts of 38~46 parts of Radix Clematidis of 26~30 parts of Fructus Psoraleaes of Radix Rhodiolae
26~30 parts of 35~42 parts of Pulvis Fumi Carbonisatuss of 32~38 parts of Rhizoma Polygonatis of Rhizoma Chuanxiong
26~30 parts of 23~26 parts of Radix Salviae Miltiorrhizaes of 29~34 portions of Radix Glehniaes of Rhizoma Gymnadeniae
26~30 parts of 29~34 portions of Aloes of 23~26 portions of Ganoderma lucidum seu Japonicumes of Rhizoma Cynanchi Stauntonii
26~30 parts of Radix Oenotherae erythrosepalaes.
3, a kind of medicine pill for the treatment of diabetes according to claim 1, wherein the weight proportion of each raw material is:
35 parts of 42 parts of Radix Clematidis of 28 parts of Fructus Psoraleaes of Radix Rhodiolae
28 parts of 37 parts of Pulvis Fumi Carbonisatuss of 35 parts of Rhizoma Polygonatis of Rhizoma Chuanxiong
28 parts of 24 parts of Radix Salviae Miltiorrhizaes of 31 portions of Radix Glehniaes of Rhizoma Gymnadeniae
28 parts of 31 portions of Aloes of 24 portions of Ganoderma lucidum seu Japonicumes of Rhizoma Cynanchi Stauntonii
28 parts of Radix Oenotherae erythrosepalaes.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CNB2005100866255A CN1305506C (en) | 2005-10-17 | 2005-10-17 | Chinese medicinal pill for treating diabetes mellitus |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CNB2005100866255A CN1305506C (en) | 2005-10-17 | 2005-10-17 | Chinese medicinal pill for treating diabetes mellitus |
Publications (2)
Publication Number | Publication Date |
---|---|
CN1745810A true CN1745810A (en) | 2006-03-15 |
CN1305506C CN1305506C (en) | 2007-03-21 |
Family
ID=36165628
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CNB2005100866255A Expired - Fee Related CN1305506C (en) | 2005-10-17 | 2005-10-17 | Chinese medicinal pill for treating diabetes mellitus |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN1305506C (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104435497A (en) * | 2014-11-07 | 2015-03-25 | 成都医路康医学技术服务有限公司 | Traditional Chinese medicinal composition for treating diabetic feet |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1066332C (en) * | 1994-02-04 | 2001-05-30 | 河北省沧州中药厂 | Hypoglycemic compound capsule |
CN1115156C (en) * | 2000-04-17 | 2003-07-23 | 李熙德 | Antisenility Chinese medicine |
CN1139398C (en) * | 2001-04-29 | 2004-02-25 | 刘杰 | Chinese medicine for treating diabetic neural lesion |
-
2005
- 2005-10-17 CN CNB2005100866255A patent/CN1305506C/en not_active Expired - Fee Related
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104435497A (en) * | 2014-11-07 | 2015-03-25 | 成都医路康医学技术服务有限公司 | Traditional Chinese medicinal composition for treating diabetic feet |
Also Published As
Publication number | Publication date |
---|---|
CN1305506C (en) | 2007-03-21 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN102058673B (en) | Chinese medicine composition for expelling wind and removing dampness and preparation method thereof | |
CN1712054A (en) | Qinchuan Tongbi tablet | |
CN1698735A (en) | Medicine for treating psoriasis | |
CN1840160A (en) | Powder for resisting hyperosteogeny | |
CN1054528C (en) | Already prepared traditional Chinese medicine for treating psoriasis named "kangyinlin" | |
CN1305506C (en) | Chinese medicinal pill for treating diabetes mellitus | |
CN1709314A (en) | Medicinal liquor for treating rheumatic arthrolithiasis and its preparing method | |
CN105796739A (en) | Method for preparing traditional Chinese medicinal composition for treating geriatric fracture | |
CN1709458A (en) | Medicine for treating coronary clisease | |
CN101125174A (en) | Traditional Chinese medicine pill for treating chronic pharyngitis | |
CN100335119C (en) | Chinese medicinal composition for treating enteritis | |
CN1879783A (en) | A medicine for treating diabetes | |
CN1895357A (en) | Chinese medicine for treating kidney insufficiency | |
CN1055226C (en) | Medicine for curing trichomadesis and its preparation method | |
CN1183942C (en) | Chinese medicine pill for treating cough | |
CN102805847B (en) | Medicine for treating arthralgia | |
CN1212149C (en) | Cinese material medical preparation for curing children' hyperkinetic symptom and the preparation process thereof | |
CN1177605C (en) | Pill for treating rheumatic carditis | |
CN1305508C (en) | Pill for treating coronary heart disease | |
CN1172710C (en) | Pill capable of treating hepatogastric disease | |
CN1190224C (en) | Medicine for treating stomach trouble | |
CN1927349A (en) | Traditional Chinese medicine for treating rheumatism and its preparing process | |
CN1172709C (en) | Medicine for treating rheumatalgia | |
CN1074928C (en) | Medicine for curing hemiplegia and its preparing process | |
CN106039028A (en) | Blood-glucose reducing pill and preparation method thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
C17 | Cessation of patent right | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20070321 Termination date: 20091117 |